Cash Flow Statement
Growth Metrics

Sintx Technologies (SINT) Net Income towards Common Stockholders Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 98.96%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.60%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Sintx Technologies 8.71 Mn 6.82 Mn 144,000.00 -22.87%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -22.87%
Dec 31, 2025 -30.68%
Sep 30, 2025 -64.42%
Jun 30, 2025 7.87%
Mar 31, 2025 38.48%
Dec 31, 2024 77.82%
Sep 30, 2024 -75.94%
Jun 30, 2024 26.97%
Mar 31, 2024 15.98%
Dec 31, 2023 30.58%
Sep 30, 2023 -30.18%
Jun 30, 2023 -31.49%
Mar 31, 2023 -56.13%
Dec 31, 2022 -288.94%
Sep 30, 2022 -16.26%
Jun 30, 2022 -19.15%
Mar 31, 2022 -8.05%
Dec 31, 2021 -151.09%
Sep 30, 2021 6.73%
Jun 30, 2021 45.41%
Mar 31, 2021 12.15%
Dec 31, 2020 449.46%
Sep 30, 2020 -29.82%
Jun 30, 2020 -8.28%
Mar 31, 2020 -83.98%
Dec 31, 2019 -50.24%
Sep 30, 2019 86.26%
Jun 30, 2019 -70.56%
Mar 31, 2019 56.22%
Dec 31, 2018 -124.68%
Sep 30, 2018 -580.76%
Jun 30, 2018 -28.07%
Mar 31, 2018 -626.76%
Dec 31, 2017 480.31%
Sep 30, 2017 81.95%
Jun 30, 2017 66.37%
Mar 31, 2017 84.89%
Dec 31, 2016 54.40%
Sep 30, 2016 -13.15%
Jun 30, 2016 14.65%
Mar 31, 2016 37.04%
Dec 31, 2015 74.58%
Sep 30, 2015 -105.45%
Jun 30, 2015 55.19%
Mar 31, 2015 -14.17%
Dec 31, 2014 -1,564.95%
Sep 30, 2014 -110.05%
Jun 30, 2014 -331.80%
Mar 31, 2014 -33.36%